Clinical trial · Interventional
A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in IMRT for Head and Neck Cancer
A New Delineation Approach for Oral Cavity, Oropharynx, Larynx and Hypopharynx in Intensity-modulated Radiation Treatment for Head and Neck Cancer
NCT05539144CI-TRIAL-00077272completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The investigators tries a new method to delineating the oral cavity, oropharynx, larynx and hypopharynx, and use the head-and-neck region to test whether the method can to create a good IMRT plan, and alleviate the oral radiation injury, reduce the incidence of adverse reactions.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
| Oropharynx Abnormality | — | UNRESOLVED | — |
| Radiotherapy | — | UNRESOLVED | — |
| Radiotherapy; Adverse Effect | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| "Oropharyngeal mucosa" | Radiation | — | UNRESOLVED |
| oropharynx | Radiation | — | UNRESOLVED |
| oropharynx and "oropharyngeal mucosa" | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- EXPERIMENTAL
- label
- "Oropharyngeal mucosa" as OARs
- description
- "Oropharyngeal mucosa" was delineated as OARs and limiting its dose
- interventionNames
- Radiation: "Oropharyngeal mucosa"
- type
- EXPERIMENTAL
- label
- oropharynx as OARs
- description
- Oropharynx was delineated as OARs and limiting its dose
- interventionNames
- Radiation: oropharynx
- type
- EXPERIMENTAL
- label
- Oropharynx and "oropharyngeal mucosa"as OARs
- description
- Oropharynx and "oropharyngeal mucosa" was delineated as OARs and limiting its dose
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: \- patients with previously untreated of the head and neck cancer who received definitive IMRT at our institution Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.